<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05121961</url>
  </required_header>
  <id_info>
    <org_study_id>RSCH1923</org_study_id>
    <nct_id>NCT05121961</nct_id>
  </id_info>
  <brief_title>Treatment for Sacroiliac Joint Pain Using Platelet-rich Plasma (PRP) Versus Steroid/Anesthetic</brief_title>
  <official_title>Treatment for Sacroiliac Joint Pain Using Platelet-rich Plasma (PRP) Regenerative Therapy: A Randomized Controlled Trial in Comparison With Steroid/Anesthetic Injection With Advanced MR Analysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Utah</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Radiological Society of North America</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Utah</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if platelet-rich plasma is superior to&#xD;
      steroid/anesthetic for the treatment of sacroiliac joint pain.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients with sacroiliac joint pain diagnosed by a back pain specialist will undergo&#xD;
      physical examination maneuvers and a test lidocaine injection of the joint. Patients who meet&#xD;
      eligibility requirements will be randomized in a single-blind randomized controlled manner&#xD;
      with a 50% chance of receiving platelet-rich plasma versus steroid/anesthetic injection of&#xD;
      the sacroiliac joint(s).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 22, 2020</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Single-blind randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Patients will be blinded to which injectate they received.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Numeric Rating Scale</measure>
    <time_frame>Change between baseline and 3-months post-intervention</time_frame>
    <description>Validated pain scale rating pain on a scale of 0 through 10. 0 for no pain, and 10 for the highest pain the patient can imagine.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Modified Oswestry Disability Questionnaire</measure>
    <time_frame>Change between baseline and 3-months post-intervention</time_frame>
    <description>Validated questionnaire used to evaluate function in patients with low back pain. The final score/index ranges from 0-100. A score of 0-20 reflects minimal disability, 21-40 moderate disability, 41-60 severe disability, 61-80 crippled, and 81-100 bed-bound.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short-Form 12 Survey</measure>
    <time_frame>Change between baseline and 3-months post-intervention</time_frame>
    <description>Validated survey used to evaluate function in patients with low back pain. Scores range from 0 to 100, with higher scores indicating better physical and mental health functioning.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional testing</measure>
    <time_frame>Change between baseline and 3-months post-intervention</time_frame>
    <description>2 validated tests for low back pain &quot;get up and go,&quot; &quot;5 time sit to stand.&quot; Shorter times indicate better physical function, and longer times indicate poorer physical function.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opiate/pain medication usage questionnaire</measure>
    <time_frame>Change between baseline and 3-months post-intervention</time_frame>
    <description>Questionnaire on type, dose, and frequency of pain medications being used by the patient. All opiates will be converted to the morphine milligram equivalent scale with lower values indicating lower opiate content and higher values indicating higher opiate content</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Low Back Pain</condition>
  <condition>Sacroiliac Joint Synovitis</condition>
  <arm_group>
    <arm_group_label>Platelet-rich Plasma</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive an intra-articular injection 3 mL of autologous platelet-rich plasma in the sacroiliac joint.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Steroid/Anesthetic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive an intra-articular injection 40 mg Depo-medrol mixed with 2 mL 0.25% bupivicaine in the sacroiliac joint.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sacroiliac intra-articular injection</intervention_name>
    <description>CT guided injection of platelet-rich plasma versus steroid/anesthetic into the sacroiliac joint</description>
    <arm_group_label>Platelet-rich Plasma</arm_group_label>
    <arm_group_label>Steroid/Anesthetic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult (&gt;18 y/o) males and females referred for therapeutic injection to the&#xD;
             investigators spine interventional service by a physiatrist or pain anesthesiologist&#xD;
             with a clinical diagnosis of SIJ pain confirmed by history&#xD;
&#xD;
          -  50% or greater reduction in pain by a diagnostic anesthetic block using no more than&#xD;
             1.5 cc 2% lidocaine performed under imaging guidance by a pain interventionalist&#xD;
             (PM&amp;R, Pain Anesthesia, or Neuroradiology Spine Intervention).&#xD;
&#xD;
          -  Baseline pain must be &gt;/=4 by numeric rating scale (NRS), at least 6 weeks in&#xD;
             chronicity, and must not be multi-factorial (related to radiculopathy or axial pain&#xD;
             localizing elsewhere) by physical examination or confounding medical history&#xD;
             (infection, inflammatory spondyloarthropathy, or osseous metastatic disease).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  SIJ steroid treatment within the prior 6 months.&#xD;
&#xD;
          -  Patients with a history of infection currently on antibiotic therapy&#xD;
&#xD;
          -  Usage of systemic immunosuppressants&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miriam Peckham, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Utah</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mariya A Chadovich</last_name>
    <phone>801-916-0582</phone>
    <email>Mariya.Chadovich@hsc.utah.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Suyi Niu</last_name>
    <phone>801-585-1021</phone>
    <email>Suyi.Niu@hsc.utah.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mariya Chadovich</last_name>
      <phone>801-916-0582</phone>
      <email>Mariya.Chadovich@hsc.utah.edu</email>
    </contact>
    <contact_backup>
      <last_name>Suyi Niu</last_name>
      <phone>801-585-1021</phone>
      <email>Suyi.Niu@hsc.utah.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Miriam Peckham, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zachary McCormick, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lubdha Shah, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Troy Hutchins, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yoshimi Anzai, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Veterans Administration Salt Lake City Health Care System</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84148</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mariya Chadovich</last_name>
      <phone>801-916-0582</phone>
      <email>Mariya.Chadovich@hsc.utah.edu</email>
    </contact>
    <contact_backup>
      <last_name>Suyi Niu</last_name>
      <phone>801-585-1021</phone>
      <email>Suyi.Niu@hsc.utah.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Miriam Peckham, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lubdha Shah, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Troy Hutchins, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yoshimi Anzai, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 20, 2021</study_first_submitted>
  <study_first_submitted_qc>November 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 16, 2021</study_first_posted>
  <last_update_submitted>November 3, 2021</last_update_submitted>
  <last_update_submitted_qc>November 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Utah</investigator_affiliation>
    <investigator_full_name>Miriam Peckham</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthralgia</mesh_term>
    <mesh_term>Synovitis</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 14, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/61/NCT05121961/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 18, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/61/NCT05121961/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

